LivaNova PLC Ordinary Shares (LIVN) Financials
Key financial figures for LivaNova PLC Ordinary Shares (Q3 2026).
LivaNova's third-quarter revenue rose 9.9% to $393.1 million and the company raised its 2026 revenue-growth and adjusted EPS guidance, while GAAP diluted EPS was $0.11 versus $0.49 a year earlier. Revenue was $393.1 million, up 9.9% reported and 10.0% in constant currency from $357.8 million a year earlier. Cardiopulmonary revenue rose 10.9% to $225.3 million on consumables demand, Essenz Perfusion System sales and favorable realized price; Neuromodulation rose 11.1% to $166.1 million on higher volume and favorable realized price. Adjusted diluted EPS was $1.23 versus $1.11 a year earlier, and adjusted operating income was $92.3 million versus $80.4 million (adjusted operating margin 23.5% versus 22.5%). On the outlook: Full-year 2026 revenue growth raised to 9% to 10% in constant currency (from 8% to 9%), with foreign currency expected to be a tailwind of about 1%; adjusted diluted EPS raised to $4.40 to $4.50 (from $4.30 to $4.40) on about 56 million shares; adjusted free cash flow maintained at $140 million to $160 million. Figures are for Q3 2026, as LivaNova PLC reported them.
- Revenue
- $393M
- Net Income
- $34M
- EPS
- $0.62
- Total Assets
- $2.7B
- Operating Cash Flow
- $74M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $393M | $34M | $0.60 | 7.22% | $43M |
| Q2 FY2026 | $391M | $109M | $1.93 | 12.67% | $35M |
| Q1 FY2026 | $362M | $22M | $0.40 | 14.41% | $926K |
| Q4 FY2025 | $361M | $31M | $0.57 | 11.81% | $50M |
| Q3 FY2025 | $358M | $27M | $0.49 | 15.09% | $62M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $1.4B | -$243M | -$4.45 | 14.36% | $173M |
| FY2024 | $1.3B | $63M | $1.16 | 10.3% | $136M |
| FY2023 | $1.2B | $18M | $0.32 | -5.94% | $40M |
Frequently asked questions
What was LivaNova PLC's revenue last quarter?
LivaNova PLC reported revenue of $393.1 million for Q3 FY2026, up 9.9% from the same period a year earlier.
Is LivaNova PLC profitable?
Yes. LivaNova PLC reported net income of $34.3 million for Q3 FY2026, a net margin of 8.73% on revenue.
How has LivaNova PLC's margin trended?
Operating margin was 7.22% in Q3 FY2026, compared with 15.09% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did LivaNova PLC generate?
LivaNova PLC generated free cash flow of $42.8 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for LivaNova PLC Ordinary Shares on SentiSense, with up to forty quarters and twenty fiscal years of history.